November 09th, 2018

MedDay Pharmaceuticals Announces Full Patient Enrollment for MD1003 Phase III Clinical Trial (SPI2) in Progressive Multiple Sclerosis
Read more

July 26th, 2018

MedDay Appoints Industry Leader Christian Chavy as Chief Executive Officer
Read more
See all recent news
April 16 2019

MedDay attends les "Journées de Neurologie de Langue Française" (JNLF) 2019 in Lille, France

December 17 2018

Meet us at the 20th "Rencontres de Neurologie" Meeting in Paris, France, at "le Palais des Congrès"

October 10 2018

MedDay attends the 34th congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Berlin, Germany

September 27 2018

MedDay attends the 31st congress of "Association des Neurologues Libéraux de Langue française" (ANLLF) in Rennes, France

June 16 2018

MedDay attends the 4th congress of the European Academy of Neurology (EAN) in Lisbon, Portugal

See all events